SECTION 1
Objectives of the current project

SECTION 2

INFORMATION ON PARTICIPANTS
Australia

Austria

Canada

France

Germany

Italy

Netherlands

Slovakia

Spain

Switzerland

UK

Advisers

SECTION 3

Results

Definition of terms 

SECTION 4

Reference list

SECTION 5

A collaborative study of CJD in the European Union was funded by the European Commission through the BIOMED1 programme in 1993.  From 1993-1995 data was compared from national registries for CJD in France, Germany, Italy, the Netherlands, Slovakia, Spain and the United Kingdom.  The principal goal of this analysis was to determine whether the incidence of Creutzfeldt-Jakob disease was similar throughout the EU, and if there was any major difference between putative risk factors in various countries.  This project was extended in 1997, through BIOMED2, to include Austria, Australia, Canada and Switzerland.  This harmonisation of projects has provided a unique framework to study putative risk factors for Creutzfeldt-Jakob disease, a disease of great potential public health and economic importance, following the occurrence of Bovine Spongiform Encephalopathy (BSE) and the description of a new variant of CJD which has been proposed to be causally linked to BSE.

This site was last updated on 8th August 2008 by Jan Mackenzie, National CJD Surveillance Unit, Western General Hospital, Edinburgh.  Please use the e-mail address below if you have any comments/queries about this site.

Return to HOME PAGE